ArticleInternational journal of molecular sciences2025

Intra-Articular Administration of Recombinant Human Proteoglycan 4 (rhPRG4) as a Potential Therapy for Temporomandibular Joint Osteoarthritis: A Preclinical Histopathological Study.

Veronica Iturriaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.